Federal award (BPA CALL, fiscal year 2023)
Recipient: CERILLIANT CORPORATION
Awarding agency: Department of Defense / Defense Health Agency
Funding agency: Department of Defense / Defense Health Agency
Period of performance: 2024-06-07 to 2024-09-30
Current total value of award: $10010.88
Description: DRUG STANDARDS USED FOR SCREENING AND ATION TESTING OF URINE, BLOOD AND TISSUE SAMPLES FROM SERVICE MEMBERS SUSPECTED OF DRUG USE.